List View

Displaying 1,576 - 1,600 of 2,573

Advances in Targeted Therapy in Lung Cancer

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC

Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC

New Developments in CLL

New Developments in CLL

Modern Challenges and New Options for B-cell NHL

Modern Challenges and New Options for B-cell NHL

Update on T-cell Lymphomas

Update on T-cell Lymphomas

Most Relevant News in Multiple Myeloma in 2022

Pharmacotherapy Management in Chronic Lymphocytic Leukemia (CLL)

Contemporary Pharmacotherapy Management of High-grade Gliomas

Antiemesis: A comparison of Treatment Approach between NCCN and ASCO Guidelines

Pharmacologic Review of Cardiotoxic Chemotherapies

Lung Cancer Screening / Tobacco Control

Lung Cancer Screening / Tobacco Control

Pulmonary – From Diagnostics to Therapeutics

Pulmonary – From Diagnostics to Therapeutics

Surgery for Early-Stage NSCLC

Surgery for Early-Stage NSCLC

Adjuvant/Neo-adjuvant Systemic Therapy

Adjuvant/Neo-adjuvant Systemic Therapy

Radiation in Early-Stage NSCLC